Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.79 |
| ▸ | THRB | P10828 | 1/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.69 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.56 |
| ▸ | CD69 | Q07108 | 1/20 | 0.51 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20281076 | 1.00 | ALDH1A1 (0.79) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL13096289 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL20990354 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22059479 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL23332629 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL23719677 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL24936522 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL23323248 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL21029771 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 | |
| SCHEMBL22058769 | 0.89 | ALDH1A1 (0.78) | ALDH1A1THRBMAPK1SMN1; SMN2CD69 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230357301-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA (PT) | 2023-11-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230357301-A1 | HEXOSE DERIVATIVES, PREPARATION AND USES THEREOF | HK1, SLC5A1, HK2 | ALDH1A1 857/4885THRB 1747/4885MAPK1 352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.